[1]
M. Piliang, “Sustained hair regrowth with ritlecitinib to Week 48 in patients with alopecia areata: post hoc analysis of the ALLEGRO phase 2b/3 study”,
J of Skin
, vol. 7, no. 2, p. s188, Mar. 2023.